Table of Content

1 Study Coverage
1.1 Neurological Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Non-prescription drugs
1.2.3 Prescription
1.3 Market by Application
1.3.1 Global Neurological Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neurological Drugs Sales Estimates and Forecasts 2018-2034
2.2 Global Neurological Drugs Revenue by Region
2.2.1 Global Neurological Drugs Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Neurological Drugs Revenue by Region (2018-2023)
2.2.3 Global Neurological Drugs Revenue by Region (2024-2034)
2.2.4 Global Neurological Drugs Revenue Market Share by Region (2018-2034)
2.3 Global Neurological Drugs Sales Estimates and Forecasts 2018-2034
2.4 Global Neurological Drugs Sales by Region
2.4.1 Global Neurological Drugs Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Neurological Drugs Sales by Region (2018-2023)
2.4.3 Global Neurological Drugs Sales by Region (2024-2034)
2.4.4 Global Neurological Drugs Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Neurological Drugs Sales by Manufacturers
3.1.1 Global Neurological Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Neurological Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurological Drugs in 2024
3.2 Global Neurological Drugs Revenue by Manufacturers
3.2.1 Global Neurological Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Neurological Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Neurological Drugs Revenue in 2024
3.3 Global Key Players of Neurological Drugs, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Neurological Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Neurological Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Neurological Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Neurological Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurological Drugs Sales by Type
4.1.1 Global Neurological Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Neurological Drugs Forecasted Sales by Type (2024-2034)
4.1.3 Global Neurological Drugs Sales Market Share by Type (2018-2034)
4.2 Global Neurological Drugs Revenue by Type
4.2.1 Global Neurological Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Neurological Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Neurological Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Neurological Drugs Price by Type
4.3.1 Global Neurological Drugs Price by Type (2018-2023)
4.3.2 Global Neurological Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Neurological Drugs Sales by Application
5.1.1 Global Neurological Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Neurological Drugs Forecasted Sales by Application (2024-2034)
5.1.3 Global Neurological Drugs Sales Market Share by Application (2018-2034)
5.2 Global Neurological Drugs Revenue by Application
5.2.1 Global Neurological Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Neurological Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Neurological Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Neurological Drugs Price by Application
5.3.1 Global Neurological Drugs Price by Application (2018-2023)
5.3.2 Global Neurological Drugs Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Neurological Drugs Market Size by Type
6.1.1 US & Canada Neurological Drugs Sales by Type (2018-2034)
6.1.2 US & Canada Neurological Drugs Revenue by Type (2018-2034)
6.2 US & Canada Neurological Drugs Market Size by Application
6.2.1 US & Canada Neurological Drugs Sales by Application (2018-2034)
6.2.2 US & Canada Neurological Drugs Revenue by Application (2018-2034)
6.3 US & Canada Neurological Drugs Market Size by Country
6.3.1 US & Canada Neurological Drugs Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Neurological Drugs Sales by Country (2018-2034)
6.3.3 US & Canada Neurological Drugs Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Neurological Drugs Market Size by Type
7.1.1 Europe Neurological Drugs Sales by Type (2018-2034)
7.1.2 Europe Neurological Drugs Revenue by Type (2018-2034)
7.2 Europe Neurological Drugs Market Size by Application
7.2.1 Europe Neurological Drugs Sales by Application (2018-2034)
7.2.2 Europe Neurological Drugs Revenue by Application (2018-2034)
7.3 Europe Neurological Drugs Market Size by Country
7.3.1 Europe Neurological Drugs Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Neurological Drugs Sales by Country (2018-2034)
7.3.3 Europe Neurological Drugs Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Neurological Drugs Market Size
8.1.1 China Neurological Drugs Sales (2018-2034)
8.1.2 China Neurological Drugs Revenue (2018-2034)
8.2 China Neurological Drugs Market Size by Application
8.2.1 China Neurological Drugs Sales by Application (2018-2034)
8.2.2 China Neurological Drugs Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Neurological Drugs Market Size by Type
9.1.1 Asia Neurological Drugs Sales by Type (2018-2034)
9.1.2 Asia Neurological Drugs Revenue by Type (2018-2034)
9.2 Asia Neurological Drugs Market Size by Application
9.2.1 Asia Neurological Drugs Sales by Application (2018-2034)
9.2.2 Asia Neurological Drugs Revenue by Application (2018-2034)
9.3 Asia Neurological Drugs Sales by Region
9.3.1 Asia Neurological Drugs Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Neurological Drugs Revenue by Region (2018-2034)
9.3.3 Asia Neurological Drugs Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Neurological Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Neurological Drugs Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Neurological Drugs Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Neurological Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Neurological Drugs Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Neurological Drugs Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Neurological Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Neurological Drugs Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Neurological Drugs Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Neurological Drugs Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Ely Lilly
11.2.1 Ely Lilly Company Information
11.2.2 Ely Lilly Overview
11.2.3 Ely Lilly Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Ely Lilly Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ely Lilly Recent Developments
11.3 Actavis
11.3.1 Actavis Company Information
11.3.2 Actavis Overview
11.3.3 Actavis Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Actavis Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Actavis Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Mylan Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Randox
11.5.1 Randox Company Information
11.5.2 Randox Overview
11.5.3 Randox Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Randox Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Randox Recent Developments
11.6 Intellipharmaceutics
11.6.1 Intellipharmaceutics Company Information
11.6.2 Intellipharmaceutics Overview
11.6.3 Intellipharmaceutics Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Intellipharmaceutics Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intellipharmaceutics Recent Developments
11.7 Astrazeneca
11.7.1 Astrazeneca Company Information
11.7.2 Astrazeneca Overview
11.7.3 Astrazeneca Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Astrazeneca Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astrazeneca Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Company Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Lundbeck Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lundbeck Recent Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Overview
11.9.3 Allergan Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Allergan Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allergan Recent Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Overview
11.10.3 GSK Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 GSK Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 Otsuka Pharmaceutical
11.11.1 Otsuka Pharmaceutical Company Information
11.11.2 Otsuka Pharmaceutical Overview
11.11.3 Otsuka Pharmaceutical Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Otsuka Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Otsuka Pharmaceutical Recent Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Overview
11.12.3 Takeda Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Takeda Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Takeda Recent Developments
11.13 NHU Group
11.13.1 NHU Group Company Information
11.13.2 NHU Group Overview
11.13.3 NHU Group Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 NHU Group Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 NHU Group Recent Developments
11.14 Shionogi
11.14.1 Shionogi Company Information
11.14.2 Shionogi Overview
11.14.3 Shionogi Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Shionogi Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Shionogi Recent Developments
11.15 APOTEX
11.15.1 APOTEX Company Information
11.15.2 APOTEX Overview
11.15.3 APOTEX Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 APOTEX Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 APOTEX Recent Developments
11.16 North China Pharmaceutical
11.16.1 North China Pharmaceutical Company Information
11.16.2 North China Pharmaceutical Overview
11.16.3 North China Pharmaceutical Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 North China Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 North China Pharmaceutical Recent Developments
11.17 Harbin Pharmaceutical Co., Ltd.
11.17.1 Harbin Pharmaceutical Co., Ltd. Company Information
11.17.2 Harbin Pharmaceutical Co., Ltd. Overview
11.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments
11.18 Lukang Pharmaceutical
11.18.1 Lukang Pharmaceutical Company Information
11.18.2 Lukang Pharmaceutical Overview
11.18.3 Lukang Pharmaceutical Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Lukang Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Lukang Pharmaceutical Recent Developments
11.19 Kelun Pharmaceutical
11.19.1 Kelun Pharmaceutical Company Information
11.19.2 Kelun Pharmaceutical Overview
11.19.3 Kelun Pharmaceutical Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Kelun Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Kelun Pharmaceutical Recent Developments
11.20 Kehua Biology
11.20.1 Kehua Biology Company Information
11.20.2 Kehua Biology Overview
11.20.3 Kehua Biology Neurological Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Kehua Biology Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Kehua Biology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurological Drugs Industry Chain Analysis
12.2 Neurological Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurological Drugs Production Mode & Process
12.4 Neurological Drugs Sales and Marketing
12.4.1 Neurological Drugs Sales Channels
12.4.2 Neurological Drugs Distributors
12.5 Neurological Drugs Customers
13 Market Dynamics
13.1 Neurological Drugs Industry Trends
13.2 Neurological Drugs Market Drivers
13.3 Neurological Drugs Market Challenges
13.4 Neurological Drugs Market Restraints
14 Key Findings in The Global Neurological Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurological Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Non-prescription drugs
Table 3. Major Manufacturers of Prescription
Table 4. Global Neurological Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Neurological Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Neurological Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Neurological Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Neurological Drugs Revenue Market Share by Region (2018-2023)
Table 9. Global Neurological Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global Neurological Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Neurological Drugs Sales by Region (2018-2023) & (K Units)
Table 12. Global Neurological Drugs Sales by Region (2024-2034) & (K Units)
Table 13. Global Neurological Drugs Sales Market Share by Region (2018-2023)
Table 14. Global Neurological Drugs Sales Market Share by Region (2024-2034)
Table 15. Global Neurological Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Neurological Drugs Sales Share by Manufacturers (2018-2023)
Table 17. Global Neurological Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Neurological Drugs Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Neurological Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 20. Neurological Drugs Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Neurological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Neurological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Drugs as of 2024)
Table 23. Global Key Manufacturers of Neurological Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Neurological Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Neurological Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 28. Global Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 29. Global Neurological Drugs Sales Share by Type (2018-2023)
Table 30. Global Neurological Drugs Sales Share by Type (2024-2034)
Table 31. Global Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Neurological Drugs Revenue Share by Type (2018-2023)
Table 34. Global Neurological Drugs Revenue Share by Type (2024-2034)
Table 35. Neurological Drugs Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Neurological Drugs Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 38. Global Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 39. Global Neurological Drugs Sales Share by Application (2018-2023)
Table 40. Global Neurological Drugs Sales Share by Application (2024-2034)
Table 41. Global Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Neurological Drugs Revenue Share by Application (2018-2023)
Table 44. Global Neurological Drugs Revenue Share by Application (2024-2034)
Table 45. Neurological Drugs Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Neurological Drugs Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Neurological Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 56. US & Canada Neurological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Neurological Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 60. Europe Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 61. Europe Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 62. Europe Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 65. Europe Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 66. Europe Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Neurological Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 69. Europe Neurological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Neurological Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 72. Europe Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 73. China Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 74. China Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 75. China Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 78. China Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 79. China Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 82. Asia Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 83. Asia Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 86. Asia Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 87. Asia Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Neurological Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 90. Asia Neurological Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Neurological Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Neurological Drugs Sales by Region (2018-2023) & (K Units)
Table 93. Asia Neurological Drugs Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Neurological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Neurological Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Neurological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Neurological Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Neurological Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Neurological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Neurological Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Pfizer Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Ely Lilly Company Information
Table 113. Ely Lilly Description and Major Businesses
Table 114. Ely Lilly Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Ely Lilly Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ely Lilly Recent Developments
Table 117. Actavis Company Information
Table 118. Actavis Description and Major Businesses
Table 119. Actavis Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Actavis Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Actavis Recent Developments
Table 122. Mylan Company Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Mylan Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Randox Company Information
Table 128. Randox Description and Major Businesses
Table 129. Randox Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Randox Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Randox Recent Developments
Table 132. Intellipharmaceutics Company Information
Table 133. Intellipharmaceutics Description and Major Businesses
Table 134. Intellipharmaceutics Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Intellipharmaceutics Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Intellipharmaceutics Recent Developments
Table 137. Astrazeneca Company Information
Table 138. Astrazeneca Description and Major Businesses
Table 139. Astrazeneca Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Astrazeneca Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Astrazeneca Recent Developments
Table 142. Lundbeck Company Information
Table 143. Lundbeck Description and Major Businesses
Table 144. Lundbeck Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Lundbeck Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lundbeck Recent Developments
Table 147. Allergan Company Information
Table 148. Allergan Description and Major Businesses
Table 149. Allergan Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Allergan Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Allergan Recent Developments
Table 152. GSK Company Information
Table 153. GSK Description and Major Businesses
Table 154. GSK Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. GSK Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. GSK Recent Developments
Table 157. Otsuka Pharmaceutical Company Information
Table 158. Otsuka Pharmaceutical Description and Major Businesses
Table 159. Otsuka Pharmaceutical Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Otsuka Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Otsuka Pharmaceutical Recent Developments
Table 162. Takeda Company Information
Table 163. Takeda Description and Major Businesses
Table 164. Takeda Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Takeda Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Takeda Recent Developments
Table 167. NHU Group Company Information
Table 168. NHU Group Description and Major Businesses
Table 169. NHU Group Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. NHU Group Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. NHU Group Recent Developments
Table 172. Shionogi Company Information
Table 173. Shionogi Description and Major Businesses
Table 174. Shionogi Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Shionogi Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Shionogi Recent Developments
Table 177. APOTEX Company Information
Table 178. APOTEX Description and Major Businesses
Table 179. APOTEX Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. APOTEX Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. APOTEX Recent Developments
Table 182. North China Pharmaceutical Company Information
Table 183. North China Pharmaceutical Description and Major Businesses
Table 184. North China Pharmaceutical Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 185. North China Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. North China Pharmaceutical Recent Developments
Table 187. Harbin Pharmaceutical Co., Ltd. Company Information
Table 188. Harbin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 189. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 190. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Harbin Pharmaceutical Co., Ltd. Recent Developments
Table 192. Lukang Pharmaceutical Company Information
Table 193. Lukang Pharmaceutical Description and Major Businesses
Table 194. Lukang Pharmaceutical Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 195. Lukang Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Lukang Pharmaceutical Recent Developments
Table 197. Kelun Pharmaceutical Company Information
Table 198. Kelun Pharmaceutical Description and Major Businesses
Table 199. Kelun Pharmaceutical Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 200. Kelun Pharmaceutical Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Kelun Pharmaceutical Recent Developments
Table 202. Kehua Biology Company Information
Table 203. Kehua Biology Description and Major Businesses
Table 204. Kehua Biology Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 205. Kehua Biology Neurological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Kehua Biology Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Neurological Drugs Distributors List
Table 210. Neurological Drugs Customers List
Table 211. Neurological Drugs Market Trends
Table 212. Neurological Drugs Market Drivers
Table 213. Neurological Drugs Market Challenges
Table 214. Neurological Drugs Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Drugs Product Picture
Figure 2. Global Neurological Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Neurological Drugs Market Share by Type in 2024 & 2034
Figure 4. Non-prescription drugs Product Picture
Figure 5. Prescription Product Picture
Figure 6. Global Neurological Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Neurological Drugs Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Neurological Drugs Report Years Considered
Figure 11. Global Neurological Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Neurological Drugs Revenue 2018-2034 (US$ Million)
Figure 13. Global Neurological Drugs Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Neurological Drugs Revenue Market Share by Region (2018-2034)
Figure 15. Global Neurological Drugs Sales 2018-2034 ((K Units)
Figure 16. Global Neurological Drugs Sales Market Share by Region (2018-2034)
Figure 17. US & Canada Neurological Drugs Sales YoY (2018-2034) & (K Units)
Figure 18. US & Canada Neurological Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Neurological Drugs Sales YoY (2018-2034) & (K Units)
Figure 20. Europe Neurological Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Neurological Drugs Sales YoY (2018-2034) & (K Units)
Figure 22. China Neurological Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Asia (excluding China) Neurological Drugs Sales YoY (2018-2034) & (K Units)
Figure 24. Asia (excluding China) Neurological Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Neurological Drugs Sales YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Neurological Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Neurological Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 28. The Top 5 and 10 Largest Manufacturers of Neurological Drugs in the World: Market Share by Neurological Drugs Revenue in 2024
Figure 29. Global Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 31. Global Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 32. Global Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 33. Global Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 34. US & Canada Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 35. US & Canada Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 36. US & Canada Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 37. US & Canada Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada Neurological Drugs Revenue Share by Country (2018-2034)
Figure 39. US & Canada Neurological Drugs Sales Share by Country (2018-2034)
Figure 40. U.S. Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 41. Canada Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 42. Europe Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 43. Europe Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 44. Europe Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 45. Europe Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 46. Europe Neurological Drugs Revenue Share by Country (2018-2034)
Figure 47. Europe Neurological Drugs Sales Share by Country (2018-2034)
Figure 48. Germany Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 49. France Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 50. U.K. Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 51. Italy Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 52. Russia Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 53. China Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 54. China Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 55. China Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 56. China Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 57. Asia Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 58. Asia Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 59. Asia Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 60. Asia Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 61. Asia Neurological Drugs Revenue Share by Region (2018-2034)
Figure 62. Asia Neurological Drugs Sales Share by Region (2018-2034)
Figure 63. Japan Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 64. South Korea Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 65. China Taiwan Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 66. Southeast Asia Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 67. India Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Neurological Drugs Sales Market Share by Type (2018-2034)
Figure 69. Middle East, Africa and Latin America Neurological Drugs Revenue Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Neurological Drugs Sales Market Share by Application (2018-2034)
Figure 71. Middle East, Africa and Latin America Neurological Drugs Revenue Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Neurological Drugs Revenue Share by Country (2018-2034)
Figure 73. Middle East, Africa and Latin America Neurological Drugs Sales Share by Country (2018-2034)
Figure 74. Brazil Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. Mexico Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. Turkey Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. Israel Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 78. GCC Countries Neurological Drugs Revenue (2018-2034) & (US$ Million)
Figure 79. Neurological Drugs Value Chain
Figure 80. Neurological Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed